Fabrizio Schipani

Research activity per year

If you made any changes in Pure these will be visible here soon.

Network

Recent external collaboration on country level. Dive into details by clicking on the dots or

Synthetic Lethality in Pancreatic Cancer: Discovery of a New RAD51-BRCA2 Small Molecule Disruptor That Inhibits Homologous Recombination and Synergizes with Olaparib
Bagnolini, G., Milano, D., Manerba, M., Schipani, F., Ortega, J. A., Gioia, D., Falchi, F., Balboni, A., Farabegoli, F., De Franco, F., Robertson, J., Pellicciari, R., Pallavicini, I., Peri, S., Minucci, S., Girotto, S., Di Stefano, G., Roberti, M. & Cavalli, A., Mar 12 2020, In: Journal of Medicinal Chemistry. 63, 5, p. 2588-2619 32 p.
Research output: Contribution to journal › Article › peer-review